|
Volumn 350, Issue 24, 2004, Pages 2524-2525
|
Thrombocytosis [5] (multiple letters)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANAGRELIDE;
HYDROXYUREA;
ANTITHROMBOCYTIC AGENT;
QUINAZOLINE DERIVATIVE;
ACUTE LEUKEMIA;
BONE MARROW SUPPRESSION;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SAFETY;
DRUG SELECTIVITY;
HIGH RISK PATIENT;
HUMAN;
LETTER;
PRIORITY JOURNAL;
THROMBOCYTE COUNT;
THROMBOCYTHEMIA;
THROMBOCYTOSIS;
THROMBOSIS;
TREATMENT OUTCOME;
NOTE;
HUMANS;
HYDROXYUREA;
PLATELET AGGREGATION INHIBITORS;
QUINAZOLINES;
THROMBOCYTOSIS;
|
EID: 2942537981
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200406103502420 Document Type: Letter |
Times cited : (5)
|
References (0)
|